Eli Lilly to Report First-Quarter Earnings Ahead of Market Open
Eli Lilly is set to report its first-quarter earnings before the market opens, with Wall Street expecting strong results driven by its GLP-1 drugs Zepbound and Mounjaro. The company's newly launched obesity drug, Foundayo, will not be included in the report but is expected to be a major topic during the earnings call.
Tickers: $LLY
Topics: Earnings Foundayo GLP-1 drugs Healthcare Mounjaro Zepbound